Kalofonos Isabel

Officer at CRNX

Sold, on record
$138k
Dollars the filings state
Form 4 sales
1
Latest Jan 5, 2026
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • CRNXCrinetics Pharmaceuticals, Inc.Officer

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice CRNXNotice
    Jan 5, 2026 2026

    Filed to sell 2,500 shares ($117k)

    Kalofonos Isabel, Officer

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale CRNXRoutine
    Jan 5, 2026 same day

    Sold 2,500 shares at $55.00 ($138k)

    Kalofonos Isabel, Chief Commercial Officer

    10b5-1 planSold 75% of holdings ($183k position)834 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Kalofonos Isabel
Source
Jan 5, 2026Jan 7, 2026CRNXChief Commercial OfficerForm 4 sale2,500$138k75.0%RoutineSEC
Jan 5, 2026Jan 5, 2026CRNXOfficerForm 144 notice2,500$117kNoticeSEC